CN Stock MarketDetailed Quotes

688266 Suzhou Zelgen Biopharmaceuticals

Watchlist
  • 67.59
  • +0.67+1.00%
Market Closed Dec 13 15:00 CST
17.89BMarket Cap-102.56P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
10.85%2.13B
47.19%2.32B
168.43%1.99B
164.68%2.11B
145.50%1.93B
44.46%1.58B
-36.41%741.02M
-29.88%797.05M
-33.80%784.34M
-21.32%1.09B
Transactional financial assets
-76.93%69.07M
-91.32%56.23M
39.97%425.77M
-44.96%137.02M
11.35%299.44M
16,052.07%647.57M
1,919.51%304.18M
281.48%248.93M
62.67%268.92M
-96.37%4.01M
Notes receivable and accounts receivable
47.55%132.64M
19.15%130.88M
18.70%112.02M
13.66%101.14M
33.52%89.89M
198.89%109.85M
976.61%94.38M
42.67%88.99M
110.62%67.33M
-16.94%36.75M
-Accounts receivable
47.55%132.64M
19.15%130.88M
18.70%112.02M
13.66%101.14M
33.52%89.89M
198.89%109.85M
976.61%94.38M
42.67%88.99M
110.62%67.33M
-16.94%36.75M
Other receivables (including interest and dividends)
-13.40%9.53M
-14.89%9.36M
-22.16%10.23M
-12.92%10.89M
-9.86%11.01M
-13.69%11M
9.05%13.14M
0.47%12.51M
2.06%12.21M
131.99%12.74M
-Other receivable
----
-14.89%9.36M
----
-12.92%10.89M
----
-13.69%11M
----
0.47%12.51M
----
131.99%12.74M
Advance payment
2.71%56.17M
-12.67%44.91M
14.70%51.9M
13.37%46.25M
15.45%54.69M
-0.29%51.42M
-19.32%45.25M
-21.58%40.8M
-9.62%47.37M
-6.12%51.57M
Inventories
39.63%160.29M
27.08%141.12M
31.25%130.43M
12.00%110.85M
46.62%114.79M
57.63%111.05M
54.84%99.38M
90.67%98.98M
60.44%78.29M
81.78%70.45M
Other current assets
-30.80%3M
-6.90%2.96M
33.47%3.51M
0.84%4.54M
43.38%4.34M
-54.99%3.18M
-90.00%2.63M
-82.21%4.5M
-90.55%3.03M
-78.77%7.07M
Total current assets
2.62%2.57B
7.78%2.71B
109.46%2.72B
95.11%2.52B
98.16%2.5B
97.08%2.51B
-3.55%1.3B
-8.12%1.29B
-17.40%1.26B
-23.91%1.27B
Non Current assets
Other equity investment
-40.12%5.99M
-40.12%5.99M
-40.12%5.99M
-40.12%5.99M
0.00%10M
0.00%10M
0.00%10M
0.00%10M
0.00%10M
0.00%10M
Fixed assets
----
0.06%107.29M
----
-10.00%98.29M
----
6.57%107.23M
----
10.08%109.21M
----
14.30%100.62M
Constru in process
----
53.98%146.91M
----
56.71%135.83M
----
76.48%95.41M
----
218.12%86.67M
----
519.23%54.06M
Intangible assets
-25.94%54.14M
-24.29%59.52M
-22.51%64.38M
-23.90%69.27M
-26.40%73.11M
-24.50%78.6M
-23.60%83.08M
-21.72%91.03M
-8.35%99.33M
-9.41%104.12M
Long deferred expense
55.39%27.04M
52.94%28.75M
-23.37%15.22M
-21.79%16.39M
37.47%17.4M
48.33%18.8M
46.38%19.87M
60.89%20.96M
80.30%12.66M
70.97%12.67M
Usufruct assets
-8.02%37.05M
-8.86%39.65M
-12.01%42.4M
-27.56%37.09M
-26.51%40.27M
-21.70%43.5M
-18.31%48.18M
-18.02%51.2M
-16.77%54.81M
561.11%55.55M
Other non current assets
-49.37%7.17M
-16.35%5.82M
-43.86%4.06M
-46.28%4.02M
-23.31%14.17M
-51.91%6.96M
-67.66%7.23M
-36.49%7.48M
-25.83%18.47M
4.96%14.48M
Total non current assets
11.86%401.9M
9.27%393.92M
4.60%381.75M
-2.57%366.87M
-3.28%359.3M
2.56%360.5M
6.87%364.98M
10.75%376.56M
14.51%371.49M
39.87%351.51M
Total assets
3.78%2.97B
7.97%3.1B
86.48%3.1B
73.06%2.89B
75.08%2.86B
76.64%2.87B
-1.45%1.66B
-4.45%1.67B
-11.81%1.63B
-15.59%1.63B
Liabilities
Current liabilities
Short term loan
16.23%882.22M
38.73%914.21M
70.86%953.39M
103.47%795.16M
117.99%759.01M
255.10%658.98M
252.32%557.99M
196.49%390.79M
210.32%348.18M
44.77%185.58M
Notes payable and accounts payable
29.78%152.64M
8.08%128.86M
6.68%122.21M
-9.22%137.73M
-20.52%117.62M
-18.37%119.22M
1.88%114.56M
28.37%151.72M
58.27%147.99M
85.21%146.04M
-Notes payable
--4.5M
--4.5M
----
----
----
----
----
----
----
----
-Accounts payable
25.95%148.14M
4.31%124.36M
6.68%122.21M
-9.22%137.73M
-20.52%117.62M
-18.37%119.22M
1.88%114.56M
28.37%151.72M
58.27%147.99M
85.21%146.04M
Contract liabilities
----
----
----
----
-27.34%202.54K
-50.88%152.91K
-95.65%481.81K
-22.35%278.76K
0.00%278.76K
11.68%311.31K
Advance receipts
--38.23K
--61.16K
--84.1K
--107.03K
----
----
----
----
----
----
Salaries payable
0.65%56.08M
2.53%49.56M
27.18%53.8M
3.54%65.25M
12.76%55.72M
25.50%48.34M
48.61%42.3M
40.92%63.02M
33.50%49.42M
34.72%38.52M
Taxs payable
30.42%34.37M
11.54%36.56M
-4.72%29.95M
13.78%33.02M
-5.64%26.35M
28.27%32.78M
29.99%31.43M
15.60%29.02M
12.77%27.93M
0.08%25.56M
Other payable (including interest and dividends)
615.29%177.02M
-6.05%21.79M
9.96%32.24M
7.70%30.13M
-1.39%24.75M
-49.11%23.19M
-24.77%29.32M
63.75%27.98M
88.06%25.1M
250.15%45.57M
-Other payable
----
-6.05%21.79M
----
7.70%30.13M
----
-49.11%23.19M
----
63.75%27.98M
----
250.15%45.57M
Non current liabilities due within one year
-82.24%11.31M
-79.26%13.17M
-78.16%13.92M
0.01%63.73M
388.24%63.68M
47.47%63.53M
48.15%63.72M
46.22%63.73M
--13.04M
--43.08M
Other current liabilities
----
145.70%4.91M
6,464.36%2.61M
278.80%10.04M
9,749.96%3.57M
4,841.93%2M
-97.24%39.78K
5,580.04%2.65M
0.00%36.24K
11.68%40.47K
Total current liabilities
25.01%1.31B
23.30%1.17B
43.86%1.21B
55.68%1.14B
71.72%1.05B
95.63%948.19M
100.94%839.84M
91.44%729.19M
117.67%611.97M
76.58%484.7M
Current liabilities
Deferred tax liabilities
-39.00%6.54M
-35.19%7.65M
-29.36%8.61M
-28.07%9.58M
-26.45%10.72M
-19.82%11.8M
-17.73%12.18M
-15.50%13.32M
-13.99%14.57M
-17.25%14.72M
Long term deferred income
-32.66%12.7M
-64.46%14.02M
-75.30%10.43M
-74.37%11.55M
-48.47%18.86M
-2.42%39.44M
-4.53%42.23M
-6.26%45.04M
-29.42%36.6M
-46.77%40.42M
Lease liabilities
1.33%29.54M
-5.71%29.18M
-13.21%31.53M
-31.79%29.46M
-33.11%29.15M
-32.87%30.95M
-25.54%36.32M
-10.36%43.18M
-34.00%43.58M
331.20%46.1M
Other non current liabilities
--301.89M
--311.32M
--245.28M
--56.6M
----
----
----
----
----
----
Total non current liabilities
497.08%350.67M
340.66%362.16M
226.06%295.85M
-29.31%107.19M
-59.44%58.73M
-45.68%82.19M
-42.53%90.73M
35.41%151.64M
-12.20%144.8M
12.46%151.29M
Total liabilities
49.99%1.66B
48.61%1.53B
61.63%1.5B
41.05%1.24B
46.63%1.11B
62.01%1.03B
61.60%930.57M
78.71%880.82M
69.66%756.77M
55.49%635.99M
Shareholders equity
Paid-in capital
0.00%264.71M
0.01%264.71M
10.30%264.71M
10.30%264.71M
10.30%264.71M
10.29%264.69M
0.00%240M
0.00%240M
0.00%240M
0.00%240M
Capital reserve funds
-8.13%3.1B
-0.45%3.35B
50.37%3.35B
50.88%3.35B
52.29%3.37B
52.78%3.37B
1.49%2.23B
0.77%2.22B
0.74%2.21B
0.85%2.2B
Retained profit
-9.17%-2.08B
-12.72%-2.05B
-14.84%-2.02B
-16.38%-1.98B
-18.43%-1.9B
-21.82%-1.81B
-29.04%-1.76B
-36.84%-1.7B
-48.15%-1.61B
-53.80%-1.49B
Other composite income
1,366.78%18.22M
-382.85%-5.66M
-69.09%-5.87M
-109.38%-5.95M
65.19%-1.44M
73.57%-1.17M
47.04%-3.47M
55.07%-2.84M
25.41%-4.13M
23.38%-4.44M
Shareholders equity without minority interests
-24.75%1.3B
-13.79%1.57B
124.78%1.59B
115.10%1.63B
105.40%1.73B
91.14%1.82B
-33.67%708.99M
-36.55%759.12M
-37.43%843.3M
-34.51%950.92M
Minority interests
-103.36%-581.5K
-94.25%1.32M
-72.37%7.02M
-57.75%11.98M
-47.46%17.29M
-40.22%22.96M
-43.18%25.4M
-50.02%28.37M
-43.15%32.91M
-40.43%38.41M
Total shareholder equity
-25.53%1.3B
-14.79%1.57B
117.96%1.6B
108.87%1.64B
99.66%1.75B
86.04%1.84B
-34.05%734.39M
-37.16%787.49M
-37.66%876.21M
-34.76%989.33M
Total liabilityies and equity
3.78%2.97B
7.97%3.1B
86.48%3.1B
73.06%2.89B
75.08%2.86B
76.64%2.87B
-1.45%1.66B
-4.45%1.67B
-11.81%1.63B
-15.59%1.63B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 10.85%2.13B47.19%2.32B168.43%1.99B164.68%2.11B145.50%1.93B44.46%1.58B-36.41%741.02M-29.88%797.05M-33.80%784.34M-21.32%1.09B
Transactional financial assets -76.93%69.07M-91.32%56.23M39.97%425.77M-44.96%137.02M11.35%299.44M16,052.07%647.57M1,919.51%304.18M281.48%248.93M62.67%268.92M-96.37%4.01M
Notes receivable and accounts receivable 47.55%132.64M19.15%130.88M18.70%112.02M13.66%101.14M33.52%89.89M198.89%109.85M976.61%94.38M42.67%88.99M110.62%67.33M-16.94%36.75M
-Accounts receivable 47.55%132.64M19.15%130.88M18.70%112.02M13.66%101.14M33.52%89.89M198.89%109.85M976.61%94.38M42.67%88.99M110.62%67.33M-16.94%36.75M
Other receivables (including interest and dividends) -13.40%9.53M-14.89%9.36M-22.16%10.23M-12.92%10.89M-9.86%11.01M-13.69%11M9.05%13.14M0.47%12.51M2.06%12.21M131.99%12.74M
-Other receivable -----14.89%9.36M-----12.92%10.89M-----13.69%11M----0.47%12.51M----131.99%12.74M
Advance payment 2.71%56.17M-12.67%44.91M14.70%51.9M13.37%46.25M15.45%54.69M-0.29%51.42M-19.32%45.25M-21.58%40.8M-9.62%47.37M-6.12%51.57M
Inventories 39.63%160.29M27.08%141.12M31.25%130.43M12.00%110.85M46.62%114.79M57.63%111.05M54.84%99.38M90.67%98.98M60.44%78.29M81.78%70.45M
Other current assets -30.80%3M-6.90%2.96M33.47%3.51M0.84%4.54M43.38%4.34M-54.99%3.18M-90.00%2.63M-82.21%4.5M-90.55%3.03M-78.77%7.07M
Total current assets 2.62%2.57B7.78%2.71B109.46%2.72B95.11%2.52B98.16%2.5B97.08%2.51B-3.55%1.3B-8.12%1.29B-17.40%1.26B-23.91%1.27B
Non Current assets
Other equity investment -40.12%5.99M-40.12%5.99M-40.12%5.99M-40.12%5.99M0.00%10M0.00%10M0.00%10M0.00%10M0.00%10M0.00%10M
Fixed assets ----0.06%107.29M-----10.00%98.29M----6.57%107.23M----10.08%109.21M----14.30%100.62M
Constru in process ----53.98%146.91M----56.71%135.83M----76.48%95.41M----218.12%86.67M----519.23%54.06M
Intangible assets -25.94%54.14M-24.29%59.52M-22.51%64.38M-23.90%69.27M-26.40%73.11M-24.50%78.6M-23.60%83.08M-21.72%91.03M-8.35%99.33M-9.41%104.12M
Long deferred expense 55.39%27.04M52.94%28.75M-23.37%15.22M-21.79%16.39M37.47%17.4M48.33%18.8M46.38%19.87M60.89%20.96M80.30%12.66M70.97%12.67M
Usufruct assets -8.02%37.05M-8.86%39.65M-12.01%42.4M-27.56%37.09M-26.51%40.27M-21.70%43.5M-18.31%48.18M-18.02%51.2M-16.77%54.81M561.11%55.55M
Other non current assets -49.37%7.17M-16.35%5.82M-43.86%4.06M-46.28%4.02M-23.31%14.17M-51.91%6.96M-67.66%7.23M-36.49%7.48M-25.83%18.47M4.96%14.48M
Total non current assets 11.86%401.9M9.27%393.92M4.60%381.75M-2.57%366.87M-3.28%359.3M2.56%360.5M6.87%364.98M10.75%376.56M14.51%371.49M39.87%351.51M
Total assets 3.78%2.97B7.97%3.1B86.48%3.1B73.06%2.89B75.08%2.86B76.64%2.87B-1.45%1.66B-4.45%1.67B-11.81%1.63B-15.59%1.63B
Liabilities
Current liabilities
Short term loan 16.23%882.22M38.73%914.21M70.86%953.39M103.47%795.16M117.99%759.01M255.10%658.98M252.32%557.99M196.49%390.79M210.32%348.18M44.77%185.58M
Notes payable and accounts payable 29.78%152.64M8.08%128.86M6.68%122.21M-9.22%137.73M-20.52%117.62M-18.37%119.22M1.88%114.56M28.37%151.72M58.27%147.99M85.21%146.04M
-Notes payable --4.5M--4.5M--------------------------------
-Accounts payable 25.95%148.14M4.31%124.36M6.68%122.21M-9.22%137.73M-20.52%117.62M-18.37%119.22M1.88%114.56M28.37%151.72M58.27%147.99M85.21%146.04M
Contract liabilities -----------------27.34%202.54K-50.88%152.91K-95.65%481.81K-22.35%278.76K0.00%278.76K11.68%311.31K
Advance receipts --38.23K--61.16K--84.1K--107.03K------------------------
Salaries payable 0.65%56.08M2.53%49.56M27.18%53.8M3.54%65.25M12.76%55.72M25.50%48.34M48.61%42.3M40.92%63.02M33.50%49.42M34.72%38.52M
Taxs payable 30.42%34.37M11.54%36.56M-4.72%29.95M13.78%33.02M-5.64%26.35M28.27%32.78M29.99%31.43M15.60%29.02M12.77%27.93M0.08%25.56M
Other payable (including interest and dividends) 615.29%177.02M-6.05%21.79M9.96%32.24M7.70%30.13M-1.39%24.75M-49.11%23.19M-24.77%29.32M63.75%27.98M88.06%25.1M250.15%45.57M
-Other payable -----6.05%21.79M----7.70%30.13M-----49.11%23.19M----63.75%27.98M----250.15%45.57M
Non current liabilities due within one year -82.24%11.31M-79.26%13.17M-78.16%13.92M0.01%63.73M388.24%63.68M47.47%63.53M48.15%63.72M46.22%63.73M--13.04M--43.08M
Other current liabilities ----145.70%4.91M6,464.36%2.61M278.80%10.04M9,749.96%3.57M4,841.93%2M-97.24%39.78K5,580.04%2.65M0.00%36.24K11.68%40.47K
Total current liabilities 25.01%1.31B23.30%1.17B43.86%1.21B55.68%1.14B71.72%1.05B95.63%948.19M100.94%839.84M91.44%729.19M117.67%611.97M76.58%484.7M
Current liabilities
Deferred tax liabilities -39.00%6.54M-35.19%7.65M-29.36%8.61M-28.07%9.58M-26.45%10.72M-19.82%11.8M-17.73%12.18M-15.50%13.32M-13.99%14.57M-17.25%14.72M
Long term deferred income -32.66%12.7M-64.46%14.02M-75.30%10.43M-74.37%11.55M-48.47%18.86M-2.42%39.44M-4.53%42.23M-6.26%45.04M-29.42%36.6M-46.77%40.42M
Lease liabilities 1.33%29.54M-5.71%29.18M-13.21%31.53M-31.79%29.46M-33.11%29.15M-32.87%30.95M-25.54%36.32M-10.36%43.18M-34.00%43.58M331.20%46.1M
Other non current liabilities --301.89M--311.32M--245.28M--56.6M------------------------
Total non current liabilities 497.08%350.67M340.66%362.16M226.06%295.85M-29.31%107.19M-59.44%58.73M-45.68%82.19M-42.53%90.73M35.41%151.64M-12.20%144.8M12.46%151.29M
Total liabilities 49.99%1.66B48.61%1.53B61.63%1.5B41.05%1.24B46.63%1.11B62.01%1.03B61.60%930.57M78.71%880.82M69.66%756.77M55.49%635.99M
Shareholders equity
Paid-in capital 0.00%264.71M0.01%264.71M10.30%264.71M10.30%264.71M10.30%264.71M10.29%264.69M0.00%240M0.00%240M0.00%240M0.00%240M
Capital reserve funds -8.13%3.1B-0.45%3.35B50.37%3.35B50.88%3.35B52.29%3.37B52.78%3.37B1.49%2.23B0.77%2.22B0.74%2.21B0.85%2.2B
Retained profit -9.17%-2.08B-12.72%-2.05B-14.84%-2.02B-16.38%-1.98B-18.43%-1.9B-21.82%-1.81B-29.04%-1.76B-36.84%-1.7B-48.15%-1.61B-53.80%-1.49B
Other composite income 1,366.78%18.22M-382.85%-5.66M-69.09%-5.87M-109.38%-5.95M65.19%-1.44M73.57%-1.17M47.04%-3.47M55.07%-2.84M25.41%-4.13M23.38%-4.44M
Shareholders equity without minority interests -24.75%1.3B-13.79%1.57B124.78%1.59B115.10%1.63B105.40%1.73B91.14%1.82B-33.67%708.99M-36.55%759.12M-37.43%843.3M-34.51%950.92M
Minority interests -103.36%-581.5K-94.25%1.32M-72.37%7.02M-57.75%11.98M-47.46%17.29M-40.22%22.96M-43.18%25.4M-50.02%28.37M-43.15%32.91M-40.43%38.41M
Total shareholder equity -25.53%1.3B-14.79%1.57B117.96%1.6B108.87%1.64B99.66%1.75B86.04%1.84B-34.05%734.39M-37.16%787.49M-37.66%876.21M-34.76%989.33M
Total liabilityies and equity 3.78%2.97B7.97%3.1B86.48%3.1B73.06%2.89B75.08%2.86B76.64%2.87B-1.45%1.66B-4.45%1.67B-11.81%1.63B-15.59%1.63B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme ShangHai Stock Connect
ShangHai Stock Connect
Intraday-1.84%
Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.90%